SCROLL TO CONTINUE WITH CONTENT

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Submit
Log in
Register
Log in
- Submit
- Log in
Subscribe
Claim

Skip menu

Articles
- Latest
- Popular Articles
  
  Original Research
  Open Access
  Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)
  Hertler et al.
  Original Research
  Open Access
  Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL Study
  Saito et al.
  Original Research
  Open Access
  Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer
  Geukens et al.
- Latest Articles
  Letter to the Editor
  Cancer in conflict: The impact of the war in Ukraine on Moldova
  Horia Vulpe
  Artiom Minzatean
  Stefania Magidson
  Irena Tocino
  Rodica Mindruta-Stratan
  Lars Johan Lönnback
  Ursula Wagner
  Violina Nazaria
  Eugenia Ciubotaru
  Nicoleta Minzatean
  Veronica Ciobanu
  Sergiu Brenister
  Ludmila Circiumari
  Cristian Teglas
  Richard Sullivan
  Ruslan Baltaga
  Current Perspective
  The emerging promise of tumor mechanobiology in cancer treatment
  Papavassiliou et al.
  Letter to the Editor
  Long-lasting CRs after ibrutinib monotherapy for relapse or refractory primary CNS lymphoma (PCNSL) and primary vitreoretinal lymphoma (PVRL): Long-term results of the iLOC study by the Lymphoma Study Association (LYSA) and the French Oculo-Cerebral Lymphoma (LOC) Network (clinical trial number: NCT02542514)
  Carole Soussain
  Denis Malaise
  Sylvain Choquet
  Hervé Ghesquières
  Caroline Houillier
Publish
- For Authors
Multimedia
- - Podcasts
About
- Society
- Journal Information
- Access
  - Subscribe
  - Activate Online Access
Contact
- Contact
- Follow Us
  - New Content Alerts
  - Twitter
    External Link

Advanced search

Please enter a term before submitting your search.

Login to your account

Email/Username

Password

Show

Forgot password?

Remember me

Don’t have an account?

Create a Free Account

If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

Email*

If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

Cancel

February 2003

Volume 39Issue 3p269-406

Current Issue
Issues in Progress
Articles in Press
Archive
- Articles in Press
- Archive

Select all

Download started.
Ok

Please select at least one article in order to proceed.

Miscellaneous

Editorial Board

Published in issue: February 2003

This issue's topics

Published in issue: February 2003

ix-x

News

Published in issue: February 2003

p269-273

Full length article

The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials

A. Bottomley,
V. Vanvoorden,
H. Flechtner,
P. Therasse
on behalf of the EORTC Quality of Life Group and the EORTC Data Center

Published in issue: February 2003

p275-285

Full-Text HTML
PDF

Quality of life in patients with advanced colorectal cancer

what has been learnt?

T Conroy,
H Bleiberg,
B Glimelius

Published in issue: February 2003

p287-294

Full-Text HTML
PDF

Health effects of the Chernobyl accident: fears, rumours and the truth^☆☆This review is based on a keynote lecture at the 24th Annual Meeting of the International Association of Cancer Registries held on 25–27 June 2002 in Tampere, Finland.

Mati Rahu

Published in issue: February 2003

p295-299

Full-Text HTML
PDF

Treatment of operable breast cancer in the elderly

a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen

I.S Fentiman,
J van Zijl,
I Karydas,
...
R Margreiter,
C Legrand,
P Therasse

Published in issue: February 2003

p300-308

Full-Text HTML
PDF

Treatment of operable breast cancer in the elderly

a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy

I.S Fentiman,
M.-R Christiaens,
R Paridaens,
...
M Nagadowska,
C Legrand,
P Therasse

Published in issue: February 2003

p309-316

Full-Text HTML
PDF

Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer

P Kerbrat,
V Dieras,
N Pavlidis,
...
J Wanders,
P Fumoleau
For the EORTC Early Clinical Studies Group/New Drug Development Office

Published in issue: February 2003

p317-320

Full-Text HTML
PDF

Predictive factors for blastoid transformation in the common variant of mantle cell lymphoma

R Räty,
K Franssila,
S.-E Jansson,
H Joensuu,
U Wartiovaara-Kautto,
E Elonen

Published in issue: February 2003

p321-329

Full-Text HTML
PDF

Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer

C Dittrich,
B Coudert,
L Paz-Ares,
...
D Lacombe,
P Fumoleau
on behalf of the European Organization for Research and Treatment of Cancer—Early Clinical Studies Group/New Drug Development Programme (EORTC-ECSG/NDDP)

Published in issue: February 2003

p330-334

Full-Text HTML
PDF

Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa

D.L Patrick,
D.D Gagnon,
M.J Zagari,
R Mathijs,
J Sweetenham
for the Epoetin Alfa Study Group

Published in issue: February 2003

p335-345

Full-Text HTML
PDF

High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer

a randomised phase II-III trial of the EORTC Gastrointestinal Group

J Wils,
G.H Blijham,
Th Wagener,
...
B Genicot,
B Baron
on behalf of the EORTC Gastrointestinal Group

Published in issue: February 2003

p346-352

Full-Text HTML
PDF

The activity of raltitrexed (Tomudex®) in malignant pleural mesothelioma

an EORTC phase II study (08992)

P. Baas,
A. Ardizzoni,
F. Grossi,
...
C. Legrand,
G. Giaccone
on behalf of the EORTC Lung Cancer Group

Published in issue: February 2003

p353-357

Full-Text HTML
PDF

Intellectual outcome in children and adolescents with acute lymphoblastic leukaemia treated with chemotherapy alone: age- and sex-related differences

N von der Weid,
I Mosimann,
A Hirt,
...
F Niggli,
A Feldges,
H.P Wagner

Published in issue: February 2003

p359-365

Full-Text HTML
PDF

No evidence of involvement of germline BACH1 mutations in Finnish breast and ovarian cancer families

S.-M. Karppinen,
J. Vuosku,
K. Heikkinen,
M. Allinen,
R. Winqvist

Published in issue: February 2003

p366-371

Full-Text HTML
PDF

Does use of alternative medicine predict survival from cancer?

T Risberg,
A Vickers,
R.M Bremnes,
E.A Wist,
S Kaasa,
B.R Cassileth

Published in issue: February 2003

p372-377

Full-Text HTML
PDF

Expression of uracil DNA glycosylase (UDG) does not affect cellular sensitivity to thymidylate synthase (TS) inhibition

S.J Welsh,
S Hobbs,
G.W Aherne

Published in issue: February 2003

p378-387

Full-Text HTML
PDF

Reliability of quantitative reverse-transcriptase-PCR-based detection of tumour cells in the blood between different laboratories using a standardised protocol

F.A Vlems,
A Ladanyi,
R Gertler,
...
Z Tulassay,
G.N.P van Muijen,
I Vogel

Published in issue: February 2003

p388-396

Full-Text HTML
PDF

Interferon-gamma upregulates MUC1 expression in haematopoietic and epithelial cancer cell lines, an effect associated with MUC1 mRNA induction

P.K Reddy,
D.V Gold,
T.M Cardillo,
D.M Goldenberg,
H Li,
J.D Burton

Published in issue: February 2003

p397-404

Full-Text HTML
PDF

Editorial

Management of primary breast cancer in the elderly patient

R.W Blamey

Published in issue: February 2003

p286

Full-Text HTML
PDF

Announcement

Paediatric Update Announcement

Published in issue: February 2003

p358

Erratum

Erratum to “RhCG is downregulated in oesophageal squamous cell carcinomas, but expressed in multiple squamous epithelia”[European Journal of Cancer, 38 (2002) 1927–1936]

Bao-Sheng Chen,
Zhi-Xiong Xu,
Xin Xu,
...
Fang Wei,
Min Wu,
Ming-Rong Wang

Published in issue: February 2003

p405

Full-Text HTML
PDF

Home
Articles & Issues
Articles in Press
Current Issue
Past Issues
EJC Supplements
Collections
Special Issues
Authors
About Open Access
Author Information
EJC Author Form
Researcher Academy
Submit Manuscript
Journal
About Open Access
About the Journal
Abstracting/Indexing
Activate Online Access
Contact Information
Editorial Board
Info for Advertisers
Pricing
Sign up for e-Alerts
Subscribe
Societies
EORTC
EUSOMA
Society Information
PracticeUpdate
More Periodicals
Find a Periodical
Go to Product Catalog
Follow Us
Twitter
RSS Feed

The content on this site is intended for healthcare professionals.

We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.

Privacy Policy
Terms and Conditions
Accessibility
Help & Contact

Popular Articles

February 2003

Miscellaneous

News

Full length article

what has been learnt?

a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen

a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy

a randomised phase II-III trial of the EORTC Gastrointestinal Group

an EORTC phase II study (08992)

Editorial

Announcement

Erratum